volume 18 issue 15 pages 2124-2130

Pyrrolizines as Potential Anticancer Agents: Design, Synthesis, Caspase-3 activation and Micronucleus (MN) Induction

Publication typeJournal Article
Publication date2018-04-09
scimago Q3
wos Q2
SJR0.562
CiteScore5.8
Impact factor3.0
ISSN18715206, 18755992
Cancer Research
Pharmacology
Molecular Medicine
Abstract
Background:

For further exploration of the promising pyrrolizine scaffold and in continuation of our previous work, that proved the potential anticancer activity of the hit compound I, a new series of pyrrolizines 2-5 and 7-9 were designed and synthesized.

Methods:

Structures of the new compounds were confirmed by IR, 1H-NMR, 13C-NMR and elemental analysis. Antitumor activity for the prepared compounds against human breast adenocarcinoma (MCF-7), liver (HEPG2) and colon (HCT116) cancer cell lines was evaluated using SRB assay method.

Result:

Compounds 2, 3 and 5 were the most potent on colon cancer cells, their IC50 values were less than 5 µM. Compounds 2, 3 and 8 were the most potent on liver cancer cells, their IC50 values were less than 10 µM. As for MCF7, compounds 2, 7, 8 and 9 were the most active with IC50 values less than 10 µM. We can conclude that combining pyrrolizine scaffold with urea gave abroad spectrum anticancer agent 2 against the three tested cell lines. Micronucleus assays showed that compounds 2, 3, 8 are mutagenic and can induce apoptosis. In addition, caspase-3 activation was evaluated and compound 2 showed increase in the level of caspase-3 (9 folds) followed by 3 (8.28 folds) then 8 (7.89 folds).

Conclusion:

The obtained results encourage considering these three compounds as novel anticancer prototypes.

Found 

Top-30

Journals

1
2
Molecules
2 publications, 25%
Scientific Reports
1 publication, 12.5%
Natural Product Communications
1 publication, 12.5%
International Journal of Molecular Sciences
1 publication, 12.5%
ChemistrySelect
1 publication, 12.5%
Current Protein and Peptide Science
1 publication, 12.5%
Russian Chemical Reviews
1 publication, 12.5%
1
2

Publishers

1
2
3
MDPI
3 publications, 37.5%
Springer Nature
1 publication, 12.5%
SAGE
1 publication, 12.5%
Wiley
1 publication, 12.5%
Bentham Science Publishers Ltd.
1 publication, 12.5%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 12.5%
1
2
3
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
8
Share
Cite this
GOST |
Cite this
GOST Copy
Belal A. Pyrrolizines as Potential Anticancer Agents: Design, Synthesis, Caspase-3 activation and Micronucleus (MN) Induction // Anti-Cancer Agents in Medicinal Chemistry. 2018. Vol. 18. No. 15. pp. 2124-2130.
GOST all authors (up to 50) Copy
Belal A. Pyrrolizines as Potential Anticancer Agents: Design, Synthesis, Caspase-3 activation and Micronucleus (MN) Induction // Anti-Cancer Agents in Medicinal Chemistry. 2018. Vol. 18. No. 15. pp. 2124-2130.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.2174/1871520618666180409155520
UR - https://doi.org/10.2174/1871520618666180409155520
TI - Pyrrolizines as Potential Anticancer Agents: Design, Synthesis, Caspase-3 activation and Micronucleus (MN) Induction
T2 - Anti-Cancer Agents in Medicinal Chemistry
AU - Belal, Amany
PY - 2018
DA - 2018/04/09
PB - Bentham Science Publishers Ltd.
SP - 2124-2130
IS - 15
VL - 18
PMID - 29629667
SN - 1871-5206
SN - 1875-5992
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2018_Belal,
author = {Amany Belal},
title = {Pyrrolizines as Potential Anticancer Agents: Design, Synthesis, Caspase-3 activation and Micronucleus (MN) Induction},
journal = {Anti-Cancer Agents in Medicinal Chemistry},
year = {2018},
volume = {18},
publisher = {Bentham Science Publishers Ltd.},
month = {apr},
url = {https://doi.org/10.2174/1871520618666180409155520},
number = {15},
pages = {2124--2130},
doi = {10.2174/1871520618666180409155520}
}
MLA
Cite this
MLA Copy
Belal, Amany. “Pyrrolizines as Potential Anticancer Agents: Design, Synthesis, Caspase-3 activation and Micronucleus (MN) Induction.” Anti-Cancer Agents in Medicinal Chemistry, vol. 18, no. 15, Apr. 2018, pp. 2124-2130. https://doi.org/10.2174/1871520618666180409155520.